1. 6 versus 12 months of adjuvant trastuzumab in HER2+ early breast cancer: A systematic review and meta-analysis. Issue 10 (12th March 2021) Authors: Wang, Bi-Cheng; Xiao, Bo-Ya; Fan, Ji-Quan; Lin, Guo-He; Wang, Chang; Liu, Quentin; Zhao, Yan-Xia Other Names: Haque. Nazmul section editor. Journal: Medicine Issue: Volume 100:Issue 10(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Bayesian network analysis of immunotherapy and taxane chemotherapy as second- or later-line treatments in non-small cell lung cancer. Issue 45 (11th November 2022) Authors: Liu, Xin-Xiu; Lin, Guo-He; Wang, Bi-Cheng Journal: Medicine Issue: Volume 101:Issue 45(2022) Page Start: e31751 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection. Issue 5 (February 2016) Authors: Chen, Jian-Lin; Lao, Xiang-Ming; Lin, Xiao-Jun; Xu, Li; Cui, Bo-Kang; Wang, Jun; Lin, Guo-He; Shuang, Ze-Yu; Mao, Yi-Ze; Huang, Xin; Yun, Jing-Ping; Jin, Jie-Tian; Li, Sheng-Ping Editors: Ho., Chi-Lai Journal: Medicine Issue: Volume 95:Issue 5(2016) Page Start: e2665 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection. Issue 5 (February 2016) Authors: Chen, Jian-Lin; Lao, Xiang-Ming; Lin, Xiao-Jun; Xu, Li; Cui, Bo-Kang; Wang, Jun; Lin, Guo-He; Shuang, Ze-Yu; Mao, Yi-Ze; Huang, Xin; Yun, Jing-Ping; Jin, Jie-Tian; Li, Sheng-Ping Other Names: Ho. Chi-Lai section editor. Journal: Medicine Issue: Volume 95:Issue 5(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Corrigendum to "Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis". (26th February 2021) Authors: Wang, Bi-Cheng; Xiao, Bo-Ya; Li, Peng-Cheng; Kuang, Bo-Hua; Chen, Wang-Bing; Li, Pin-Dong; Lin, Guo-He; Liu, Quentin Journal: Journal of oncology Issue: Volume 2021(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Durvalumab and tremelimumab combination therapy versus durvalumab or tremelimumab monotherapy for patients with solid tumors: A systematic review and meta-analysis. Issue 28 (10th July 2020) Authors: Wang, Bi-Cheng; Li, Peng-Cheng; Fan, Ji-Quan; Lin, Guo-He; Liu, Quentin Other Names: Moorthy. Balaji Thas section editor. Journal: Medicine Issue: Volume 99:Issue 28(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and Safety of First-Line Immunotherapy in Combination with Chemotherapy for Patients with Extensive-Stage Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis. (29th September 2020) Authors: Wang, Bi-Cheng; Xiao, Bo-Ya; Li, Peng-Cheng; Kuang, Bo-Hua; Chen, Wang-Bing; Li, Pin-Dong; Lin, Guo-He; Liu, Quentin Other Names: You San Lin Academic Editor. Journal: Journal of oncology Issue: Volume 2020(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immunotherapy Alone or in Combination with Stereotactic Body Radiotherapy in Advanced Lung Cancer: A Pooled Analysis of Randomized Clinical Trials. (20th September 2022) Authors: Wang, Bi-Cheng; Kuang, Bo-Hua; Lin, Guo-He Other Names: Kolla Jayaprakash Academic Editor. Journal: Journal of oncology Issue: Volume 2022(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Poziotinib in non-small-cell lung cancer patients with HER2 exon 20 mutations: A pooled analysis of randomized clinical trials. Issue 44 (4th November 2022) Authors: Wang, Bi-Cheng; Kuang, Bo-Hua; Liu, Xin-Xiu; Lin, Guo-He Journal: Medicine Issue: Volume 101:Issue 44(2022) Page Start: e31337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The efficacy and safety of PD-1/PD-L1 inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis. (May 2020) Authors: Wang, Bi-Cheng; Cao, Ru-Bo; Fu, Chen; Chen, Wang-Bing; Li, Pin-Dong; Lin, Guo-He; Qian, Xiao-Jun; Li, Yun-Tian; Liu, Quentin Journal: Oral oncology Issue: Volume 104(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗